Literature DB >> 23112128

Analysis of multicentre trials with continuous outcomes: when and how should we account for centre effects?

Brennan C Kahan1, Tim P Morris.   

Abstract

In multicentre trials, randomisation is often carried out using permuted blocks stratified by centre. It has previously been shown that stratification variables used in the randomisation process should be adjusted for in the analysis to obtain correct inference. For continuous outcomes, the two primary methods of accounting for centres are fixed-effects and random-effects models. We discuss the differences in interpretation between these two models and the implications that each pose for analysis. We then perform a large simulation study comparing the performance of these analysis methods in a variety of situations. In total, we assessed 378 scenarios. We found that random centre effects performed as well or better than fixed-effects models in all scenarios. Random centre effects models led to increases in power and precision when the number of patients per centre was small (e.g. 10 patients or less) and, in some scenarios, when there was an imbalance between treatments within centres, either due to the randomisation method or to the distribution of patients across centres. With small samples sizes, random-effects models maintained nominal coverage rates when a degree-of-freedom (DF) correction was used. We assessed the robustness of random-effects models when assumptions regarding the distribution of the centre effects were incorrect and found this had no impact on results. We conclude that random-effects models offer many advantages over fixed-effects models in certain situations and should be used more often in practice.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23112128     DOI: 10.1002/sim.5667

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  34 in total

Review 1.  Many multicenter trials had few events per center, requiring analysis via random-effects models or GEEs.

Authors:  Brennan C Kahan; Michael O Harhay
Journal:  J Clin Epidemiol       Date:  2015-04-02       Impact factor: 6.437

2.  Bayesian hierarchical model for multiple repeated measures and survival data: an application to Parkinson's disease.

Authors:  Sheng Luo; Jue Wang
Journal:  Stat Med       Date:  2014-06-17       Impact factor: 2.373

Review 3.  Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use Disorders.

Authors:  Katie Witkiewitz; John W Finney; Alex H S Harris; Daniel R Kivlahan; Henry R Kranzler
Journal:  Alcohol Clin Exp Res       Date:  2015-08-06       Impact factor: 3.455

4.  The impact of a computerised test of attention and activity (QbTest) on diagnostic decision-making in children and young people with suspected attention deficit hyperactivity disorder: single-blind randomised controlled trial.

Authors:  Chris Hollis; Charlotte L Hall; Boliang Guo; Marilyn James; Janet Boadu; Madeleine J Groom; Nikki Brown; Catherine Kaylor-Hughes; Maria Moldavsky; Althea Z Valentine; Gemma M Walker; David Daley; Kapil Sayal; Richard Morriss
Journal:  J Child Psychol Psychiatry       Date:  2018-04-26       Impact factor: 8.982

5.  Including random centre effects in design, analysis and presentation of multi-centre trials.

Authors:  Kate Edgar; Ian Roberts; Linda Sharples
Journal:  Trials       Date:  2021-05-22       Impact factor: 2.279

6.  Update on the transfusion in gastrointestinal bleeding (TRIGGER) trial: statistical analysis plan for a cluster-randomised feasibility trial.

Authors:  Brennan C Kahan; Vipul Jairath; Michael F Murphy; Caroline J Doré
Journal:  Trials       Date:  2013-07-10       Impact factor: 2.279

Review 7.  Risk of selection bias in randomised trials.

Authors:  Brennan C Kahan; Sunita Rehal; Suzie Cro
Journal:  Trials       Date:  2015-09-10       Impact factor: 2.279

8.  Extending the I-squared statistic to describe treatment effect heterogeneity in cluster, multi-centre randomized trials and individual patient data meta-analysis.

Authors:  Karla Hemming; James P Hughes; Joanne E McKenzie; Andrew B Forbes
Journal:  Stat Methods Med Res       Date:  2020-09-21       Impact factor: 3.021

9.  Assessing potential sources of clustering in individually randomised trials.

Authors:  Brennan C Kahan; Tim P Morris
Journal:  BMC Med Res Methodol       Date:  2013-04-16       Impact factor: 4.615

10.  Gains in cognition through combined cognitive and physical training: the role of training dosage and severity of neurocognitive disorder.

Authors:  Panagiotis D Bamidis; Patrick Fissler; Sokratis G Papageorgiou; Vasiliki Zilidou; Evdokimos I Konstantinidis; Antonis S Billis; Evangelia Romanopoulou; Maria Karagianni; Ion Beratis; Angeliki Tsapanou; Georgia Tsilikopoulou; Eirini Grigoriadou; Aristea Ladas; Athina Kyrillidou; Anthoula Tsolaki; Christos Frantzidis; Efstathios Sidiropoulos; Anastasios Siountas; Stavroula Matsi; John Papatriantafyllou; Eleni Margioti; Aspasia Nika; Winfried Schlee; Thomas Elbert; Magda Tsolaki; Ana B Vivas; Iris-Tatjana Kolassa
Journal:  Front Aging Neurosci       Date:  2015-08-07       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.